Related Experiment Video
Updated: Dec 7, 2025

07:14
Optogenetic Phase Transition of TDP-43 in Spinal Motor Neurons of Zebrafish Larvae
Published on: February 25, 2022
6.3K
Beyond aggregation: Pathological phase transitions in neurodegenerative disease
Cécile Mathieu1, Rohit V Pappu2,3, J Paul Taylor4
1Howard Hughes Medical Institute, Department of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Summary
Cellular phase transitions are crucial for organization but their defects drive neurodegenerative diseases. Understanding these aberrant transitions offers therapeutic targets to restore cell function.
Area of Science:
- Cell Biology
- Neuroscience
- Biochemistry
Background:
- Cellular organization relies on phase transitions, a process fundamental to cell function.
- Aberrations in these phase transitions are increasingly recognized as early events in neurodegenerative disease pathogenesis.
Purpose of the Study:
- To review evidence linking phase transition defects to neurodegeneration.
- To elucidate the mechanisms underlying pathological phase transitions and their consequences.
Main Methods:
- Review of existing literature on phase transitions in cellular organization and neurodegeneration.
- Analysis of defects at protein and condensate levels.
- Discussion of key concepts like dynamical arrest and heterotypic buffering.
Main Results:
- Defects in protein and multicomponent condensate phase transitions are implicated in neurodegeneration.
- Dynamical arrest and heterotypic buffering explain cellular dysfunction and protein deposit formation.
- Pathological phase transitions contribute to pleiotropic cellular defects.
Conclusions:
- Understanding aberrant phase transitions is key to neurodegenerative disease etiology.
- These insights can guide the development of novel therapeutic strategies.
- Restoring cellular homeostasis through targeted interventions is a promising therapeutic avenue.
Related Concept Videos
Amyloid Fibrils
11.4K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
11.4K
Amyloid Fibrils
6.1K
6.1K
Alzheimer's Disease: Overview
1.4K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.4K
Parkinson's Disease: Overview
1.5K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.5K
Neural Regulation
42.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
42.6K
The Proteasome
1.4K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.4K

